A human cell-based SARS-CoV-2 vaccine elicits potent neutralizing antibody responses and protects mice from SARS-CoV-2 challenge인간 세포 기반 SARS-CoV-2 백신은 강력한 중화 항체 반응을 유도하고 SARS-CoV-2 공격으로부터 마우스를 보호합니다Research Article Published on 2021-08-122022-09-10 Journal: Emerging Microbes & Infections [Category] SARS, 변종, 진단, [키워드] acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 administration ameliorated Antibody titer approach caused Cell cell-based vaccines cellular convalescent serum coronavirus coronavirus disease Coronavirus disease 2019 COVID-19 demonstrated develop effective Efficacy elicit exposure to external gene external genes formalin generate greater hACE2 human cell immunization in viral inactivated Inactivated vaccine induce K562-S Log reduction lung Lung pathology membrane MERS-CoV mice mouse model NAb neutralizing antibody Neutralizing antibody response Neutralizing antibody titer non-human primate non-human primate model non-human primates pandemic platform promise PROTECT protection Protective Protein regimen respiratory response S-protein Safe SARS-CoV SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 mutants SARS-CoV-2 vaccine severe acute respiratory syndrome Coronavirus spike Support turn vaccination Vaccine vaccine candidate vectors viability Viral X-ray [DOI] 10.1080/22221751.2021.1957400 PMC 바로가기 [Article Type] Research Article
Locally harvested Covid-19 convalescent plasma could probably help combat the geographically determined SARS-CoV-2 viral variants지역적으로 수확된 Covid-19 회복기 혈장은 아마도 지리적으로 결정된 SARS-CoV-2 바이러스 변이체를 퇴치하는 데 도움이 될 수 있습니다Article Published on 2021-08-012022-09-11 Journal: Transfusion clinique et biologique : journal de la [Category] MERS, SARS, 변종, 진단, [키워드] administer affected Antigen AstraZeneca Bharat Blood donors Blood safety CCP combating convalescent convalescent plasma COVID-19 COVID-19 convalescent plasma COVID-19 patients Donor registry drug effective Efficacy Epitopes help herd immunity Human plasma identify Immunity Inactivated vaccine India individual inherent live vaccine mind multiple epitope multiple epitopes Novel coronavirus Oxford pandemic pandemic status pathogen polyclonal researcher rising Russia SARS-CoV-2 variant SARS-CoV-2 variants SARS-CoV-2 viral SARS-CoV-2 virus the vaccine the vaccines United Kingdom Vaccine Vaccine impact variant variants Viral Viral variants [DOI] 10.1016/j.tracli.2021.05.003 PMC 바로가기 [Article Type] Article
Safety and immunogenicity of COVID-19 vaccination in patients with non-alcoholic fatty liver disease (CHESS2101): A multicenter study비알코올성 지방간 질환 환자에서 코로나19 예방접종의 안전성과 면역원성(CHESS2101): 다기관 연구Multicenter Study Published on 2021-08-012022-09-12 Journal: Journal of hepatology [Category] MERS, SARS, 진단, [키워드] Adverse reaction appear China concern coronavirus disease COVID-19 COVID-19 vaccination COVID-19 vaccine disease dose Efficacy Fatty liver headache inactivated Inactivated vaccine incidence injection injection site pain IQR male median median age Median BMI Mild multicenter NAFLD neutralizing antibody Neutralizing antibody response Neutralizing antibody titer outcome Pain Patient primary immunogenicity progressed raised response Safe Safety SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 vaccine vaccination Vaccine were recorded [DOI] 10.1016/j.jhep.2021.04.026 PMC 바로가기 [Article Type] Multicenter Study
Immunogenicity and safety of the CoronaVac inactivated vaccine in patients with autoimmune rheumatic diseases: a phase 4 trial Research Published on 2021-07-302022-10-05 Journal: Nature Medicine [Category] 임상, [키워드] adverse events anti-SARS-CoV-2 IgG approved ARD Autoimmune control group Controlled trial CoronaVac dose Emergency use Endpoint evaluate Frequency healthy IgG IgG titer immunocompromised individual immunogenicity inactivated Inactivated vaccine initiated median neutralization activity Neutralizing activity neutralizing antibody outcome Patient Primary outcome reduced reduction rheumatic disease SARS-CoV-2 vaccine second dose secondary Seroconversion Support Trial Vaccine [DOI] 10.1038/s41591-021-01469-5 [Article Type] Research
Evaluation of the safety profile of COVID-19 vaccines: a rapid reviewResearch Article Published on 2021-07-282022-10-28 Journal: BMC Medicine [Category] COVID-19, SARS, [키워드] accounted adverse event age article candidate vaccine Candidates clinical trial clinical trials COVID-19 COVID-19 vaccine COVID-19 vaccines DNA vaccine eligible Evidence fatigue follow-up time Frequency group headache heterogeneity Human Inactivated vaccine incidence indicate Injection-site pain lack Local Meta-analysis Novel coronavirus diseases 2019 observational study outcome platform PMC pooled rate proportion protein subunit vaccine rapid process Reactions recipient Regulatory Reporting Research Result review RNA vaccine safety profile searched Serious Adverse Event severe acute respiratory syndrome coronavirus 2 significantly lower supplementary material Surveillance surveillance data systemic reaction systemic reactions treatment groups Vaccine virus-like particle vaccine was performed Web of Science [DOI] 10.1186/s12916-021-02059-5 PMC 바로가기 [Article Type] Research Article
Effect of 2 Inactivated SARS-CoV-2 Vaccines on Symptomatic COVID-19 Infection in Adults: A Randomized Clinical TrialClinical Trial Published on 2021-07-062022-10-05 Journal: JAMA [Category] 임상, [키워드] 95% CI adverse event Adverse reaction age aluminum Analysis Bahrain Chinese clinical contributed COVID-19 COVID-19 vaccines Data collection data set dose doses double-blind Effect effective vaccine Efficacy efficacy analysis Enrollment evaluate Evidence Final Follow-up group groups had no hydroxide inactivated Inactivated vaccine injection interim analysis Intramuscular injection laboratory-confirmed median men occurred Older outcome participant per 1000 person-years phase 3 trial Primary outcome randomization Randomized randomized clinical trial reaction receive reduced resulting risk SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 vaccine second dose secondary outcome Serious Adverse Event Severe case severe COVID-19 significantly strain symptomatic the vaccine Treatment United Arab Emirate Vaccine vaccine dose was collected [DOI] 10.1001/jama.2021.8565 PMC 바로가기 [Article Type] Clinical Trial
Safety of SARS-CoV-2 vaccines: a systematic review and meta-analysis of randomized controlled trialsSARS-CoV-2 백신의 안전성: 무작위 대조 시험의 체계적인 검토 및 메타 분석Meta-Analysis Published on 2021-07-052022-09-10 Journal: Infectious Diseases of Poverty [Category] 임상, [키워드] 95% CI addition adverse event adverse events Adverse events following immunization approved article candidate clinical trial clinical trials Cochrane Library confidence interval coronavirus disease Coronavirus disease 2019 COVID-19 COVID-19 vaccine COVID-19 vaccines determine first dose immunization inactivated Inactivated vaccine Local lowest mass vaccination Medical conditions medRxiv Meta-analysis mRNA vaccine no significant differences platform Randomized controlled trial Randomized controlled trials RCT RCTs reported required risk risk ratio risk ratios Safety SARS-CoV-2 second dose significant difference significant differences significantly higher subject supplementary material Surveillance systematic review Tolerance vaccination Vaccine was performed Web of Science [DOI] 10.1186/s40249-021-00878-5 PMC 바로가기 [Article Type] Meta-Analysis
SARS-CoV-2 Production in a Scalable High Cell Density BioreactorArticle Published on 2021-06-292022-10-28 Journal: Vaccines [Category] COVID-19, [키워드] acute respiratory syndrome addition animal component-free approved bioreactor carrier CelCradle Cell Cell culture cells conditions coronavirus COVID-19 Culture demonstrated density ENhance highest IMPROVE Inactivated vaccine Infection infectious dose log medium multiplicity of infection packed-bed pandemic per day Post-infection produced Production reported SARS-CoV-2 scalable bioreactor Seven severe acute respiratory syndrome coronavirus 2 TCID temperature tested tissue trypsin Vaccine vaccine production Vero Vero cells virus virus production virus spread viruses Volume while WHO whole virus vaccine [DOI] 10.3390/vaccines9070706 PMC 바로가기 [Article Type] Article
Proteomic analysis of chicken bone marrow-derived dendritic cells in response to an inactivated IBV + NDV poultry vaccineArticle Published on 2021-06-162022-10-29 Journal: Scientific Reports [Category] Coronavirus, [키워드] Activation Analysis Biomarker Cell dendritic cell differentially expressed domains eight facilitated Gene regulation in immune cells homology immune responses in vivo inactivated Inactivated vaccine increased expression Infectious Bronchitis Virus Innate immune cells lipid metabolism lysed maturation mRNA mRNA expression mRNA translation newcastle disease virus PLIN2 positive control Potential biomarker Protein protein level Proteins proteomic Proteomic analysis provide PSMB1 significantly stimulated Stimulation subject the vaccine upregulated Vaccine vaccine-induced immune responses Vaccines were assessed [DOI] 10.1038/s41598-021-89810-3 PMC 바로가기 [Article Type] Article
Intensified antibody response elicited by boost suggests immune memory in individuals administered two doses of SARS-CoV-2 inactivated vaccine부스트에 의해 유발된 강화된 항체 반응은 SARS-CoV-2 비활성화 백신을 2회 투여받은 개인의 면역 기억을 시사합니다Letter Published on 2021-06-092022-09-12 Journal: Emerging Microbes & Infections [Category] 진단, [키워드] Administered antibody Antibody Response antibody waning boost clinical trial COVID-19 dose elicited immune memory Immunity immunization inactivated Inactivated vaccine individual neutralizing antibody SARS-CoV-2 SARS-CoV-2 vaccine subject suggested [DOI] 10.1080/22221751.2021.1937328 PMC 바로가기 [Article Type] Letter